Nick Paras, PhD
|
Title(s) | Professor, Institute for Neurodegenerative Diseases |
---|
School | School of Medicine |
---|
Address | 675 Nelson Rising Lane San Francisco CA 94158
|
---|
Phone | 415-502-7122 |
---|
ORCID
.gif) | 0000-0001-5742-4056  |
---|
vCard | Download vCard |
---|
|
|
Title(s) | UCSF Weill Institute for Neurosciences |
---|
|
---|
|
Bibliographic
Altmetrics Details
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media.
(Note that publications are often cited in additional ways that are not shown here.)
Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication.
Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication.
Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.)
Click a Field or Translation tag to filter the publications.
-
Expanding spectrum of prion diseases. Emerg Top Life Sci. 2020 09 08; 4(2):155-167.
Ayers JI, Paras NA, Prusiner SB. PMID: 32803268.
View in: PubMed Mentions:
-
Discovery of 4-Piperazine Isoquinoline Derivatives as Potent and Brain-Permeable Tau Prion Inhibitors with CDK8 Activity. ACS Med Chem Lett. 2020 Feb 13; 11(2):127-132.
Grandjean JM, Jiu AY, West JW, Aoyagi A, Droege DG, Elepano M, Hirasawa M, Hirouchi M, Murakami R, Lee J, Sasaki K, Hirano S, Ohyama T, Tang BC, Vaz RJ, Inoue M, Olson SH, Prusiner SB, Conrad J, Paras NA. PMID: 32071678.
View in: PubMed Mentions:
-
AMG 176, a Selective MCL1 Inhibitor, Is Effective in Hematologic Cancer Models Alone and in Combination with Established Therapies. Cancer Discov. 2018 12; 8(12):1582-1597.
Caenepeel S, Brown SP, Belmontes B, Moody G, Keegan KS, Chui D, Whittington DA, Huang X, Poppe L, Cheng AC, Cardozo M, Houze J, Li Y, Lucas B, Paras NA, Wang X, Taygerly JP, Vimolratana M, Zancanella M, Zhu L, Cajulis E, Osgood T, Sun J, Damon L, Egan RK, Greninger P, McClanaghan JD, Gong J, Moujalled D, Pomilio G, Beltran P, Benes CH, Roberts AW, Huang DC, Wei A, Canon J, Coxon A, Hughes PE. PMID: 30254093.
View in: PubMed Mentions: 45 Fields:
-
Photoredox Cyanomethylation of Indoles: Catalyst Modification and Mechanism. J Org Chem. 2018 08 17; 83(16):8926-8935.
O'Brien CJ, Droege DG, Jiu AY, Gandhi SS, Paras NA, Olson SH, Conrad J. PMID: 29940725.
View in: PubMed Mentions: 3 Fields: Translation: Cells
-
Deutetrabenazine for Treatment of Chorea in Huntington Disease. JAMA. 2016 Jul 05; 316(1):33-5.
Geschwind MD, Paras N. PMID: 27380339.
View in: PubMed Mentions: 2 Fields: Translation: Humans
-
Convenient route to secondary sulfinates: application to the stereospecific synthesis of a-C-chiral sulfonamides. Org Lett. 2014 Dec 05; 16(23):6248-51.
Johnson MG, Gribble MW, Houze JB, Paras NA. PMID: 25415837.
View in: PubMed Mentions: 1 Fields: Translation: Cells
-
Selective inhibitors of the mutant B-Raf pathway: discovery of a potent and orally bioavailable aminoisoquinoline. J Med Chem. 2009 Oct 22; 52(20):6189-92.
Smith AL, DeMorin FF, Paras NA, Huang Q, Petkus JK, Doherty EM, Nixey T, Kim JL, Whittington DA, Epstein LF, Lee MR, Rose MJ, Babij C, Fernando M, Hess K, Le Q, Beltran P, Carnahan J. PMID: 19764794.
View in: PubMed Mentions: 11 Fields: Translation: HumansAnimalsCells
-
Solid-phase synthesis of 1-substituted tetrahydroisoquinoline derivatives employing BOC-protected tetrahydroisoquinoline carboxylic acids. J Comb Chem. 2004 Jul-Aug; 6(4):487-96.
Bunin BA, Dener JM, Kelly DE, Paras NA, Tario JD, Tushup SP. PMID: 15244409.
View in: PubMed Mentions: 3 Fields:
-
The enantioselective organocatalytic 1,4-addition of electron-rich benzenes to alpha,beta-unsaturated aldehydes. J Am Chem Soc. 2002 Jul 10; 124(27):7894-5.
Paras NA, MacMillan DW. PMID: 12095321.
View in: PubMed Mentions: 13 Fields:
-
New strategies in organic catalysis: the first enantioselective organocatalytic Friedel-Crafts alkylation. J Am Chem Soc. 2001 May 09; 123(18):4370-1.
Paras NA, MacMillan DW. PMID: 11457218.
View in: PubMed Mentions: 17 Fields: Translation: Cells
This graph shows the total number of publications by year. To see the data as text, click here.
This graph shows the total number of publications by year. To return to the graph, click here.
Year | Publications |
---|
2001 | 1 | 2002 | 1 | 2004 | 1 | 2009 | 1 | 2014 | 1 | 2016 | 1 | 2018 | 2 | 2020 | 2 |
This graph shows the number and percent of publications by field.
Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications.
Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written.
To see the data as text, click here.
This graph shows the number and percent of publications by field.
Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications.
Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written.
To see the data as text, click here.
newest
oldest
line numbers
double spacing
all authors
publication IDs
|
Derived automatically from this person's publications.
_
People in Profiles who have published with this person.
_
People who share similar concepts with this person.
_
Search Department
_
|